Ashling

Ashling company information, Employees & Contact Information

Explore related pages

Related company profiles:

Boutique by design, hyperfocused on intelligent automation. As global leaders in Intelligent Automation and digital transformation solutions, Ashling excels at uncovering valuable automation opportunities across industries and translating them into tangible results. We work across the full automation lifecycle—Discovery to Evolution—combining strategy, technology, and execution to deliver results that scale. Our edge? We blend deep platform expertise with lean delivery teams and industry-specific knowledge to move fast, solve hard problems, and unlock real business value. From agentic automation and AI/ML to RPA, IDP, low-code, and process intelligence, we architect integrated solutions that work. Whether you’re scaling automation across a global enterprise or modernizing a single workflow, we help you do it smarter, faster, and with greater return. Let’s engineer your tomorrow, today.
Looking for a particular Ashling employee's phone or email?

Ashling Questions

News

ELI-002 7P Shows Potential to Address Unmet Need in Pancreatic Ductal Adenocarcinoma - OncLive

ELI-002 7P Shows Potential to Address Unmet Need in Pancreatic Ductal Adenocarcinoma OncLive

Porustobart Plus Tislelizumab Yields Promising Responses in Pretreated MSS mCRC - OncLive

Porustobart Plus Tislelizumab Yields Promising Responses in Pretreated MSS mCRC OncLive

Atezolizumab Plus Bevacizumab Shows Early TTFS Edge Over TACE in HCC - OncLive

Atezolizumab Plus Bevacizumab Shows Early TTFS Edge Over TACE in HCC OncLive

HLC43 Nets FDA Orphan Drug Designation in Thymic Epithelial Tumors - OncLive

HLC43 Nets FDA Orphan Drug Designation in Thymic Epithelial Tumors OncLive

Bemarituzumab/Chemo Combo Translates to OS Advantage in FGFR2b+ Gastric/GEJ Cancer - OncLive

Bemarituzumab/Chemo Combo Translates to OS Advantage in FGFR2b+ Gastric/GEJ Cancer OncLive

Zanzalintinib Plus Atezolizumab Improves OS in Previously Treated Metastatic CRC - OncLive

Zanzalintinib Plus Atezolizumab Improves OS in Previously Treated Metastatic CRC OncLive

Countdown to ESMO 2025: Catch Up on OncLive’s Extensive Tumor-Specific Previews - OncLive

Countdown to ESMO 2025: Catch Up on OncLive’s Extensive Tumor-Specific Previews OncLive

Sirexatamab Plus Bevacizumab/Chemo Improves Outcomes in DKK1-High mCRC - OncLive

Sirexatamab Plus Bevacizumab/Chemo Improves Outcomes in DKK1-High mCRC OncLive

Fruquintinib Plus Sintilimab Improves PFS in Advanced RCC After First-Line VEGFR TKI Therapy - OncLive

Fruquintinib Plus Sintilimab Improves PFS in Advanced RCC After First-Line VEGFR TKI Therapy OncLive

Perioperative Serplulimab Meets Primary End Point of EFS in Gastric Cancer - OncLive

Perioperative Serplulimab Meets Primary End Point of EFS in Gastric Cancer OncLive

FDA Grants Fast Track Designation to VT3989 for Unresectable Mesothelioma - OncLive

FDA Grants Fast Track Designation to VT3989 for Unresectable Mesothelioma OncLive

CheckMate 8HW Data Further Support Nivolumab/Ipilimumab as a SOC Option in First-line MSI-H/dMMR mCRC - OncLive

CheckMate 8HW Data Further Support Nivolumab/Ipilimumab as a SOC Option in First-line MSI-H/dMMR mCRC OncLive

Targeted Therapies Move the Needle in NSCLC - OncLive

Targeted Therapies Move the Needle in NSCLC OncLive

Osimertinib Plus Local Consolidative Therapy Significantly Extends PFS in EGFR-Mutant NSCLC - OncLive

Osimertinib Plus Local Consolidative Therapy Significantly Extends PFS in EGFR-Mutant NSCLC OncLive

Poll: Vote on the Top Gynecologic and GI Cancer Abstracts/Topics to Watch at ESMO 2025 - OncLive

Poll: Vote on the Top Gynecologic and GI Cancer Abstracts/Topics to Watch at ESMO 2025 OncLive

FDA Grants Utidelone Injection Orphan Drug Designation for Pancreatic Cancer - OncLive

FDA Grants Utidelone Injection Orphan Drug Designation for Pancreatic Cancer OncLive

FDA Grants Premarket Approval to Idylla CDx MSI Test for MSI-H CRC - OncLive

FDA Grants Premarket Approval to Idylla CDx MSI Test for MSI-H CRC OncLive

Ateganosine Sequenced With Cemiplimab Displays Activity in Pretreated NSCLC - OncLive

Ateganosine Sequenced With Cemiplimab Displays Activity in Pretreated NSCLC OncLive

Taletrectinib Wins Japanese Approval for ROS1+ Advanced NSCLC - OncLive

Taletrectinib Wins Japanese Approval for ROS1+ Advanced NSCLC OncLive

Optune Lua Secures Japanese Approval for Advanced NSCLC - OncLive

Optune Lua Secures Japanese Approval for Advanced NSCLC OncLive

OncLive Fellows Forum Spotlights New Data for Tarlatamab in SCLC and PRO Results in Hospitalized Patients - OncLive

OncLive Fellows Forum Spotlights New Data for Tarlatamab in SCLC and PRO Results in Hospitalized Patients OncLive

Poll: Vote on the Top Lung, GU Cancer Abstracts to Watch at ESMO 2025 - OncLive

Poll: Vote on the Top Lung, GU Cancer Abstracts to Watch at ESMO 2025 OncLive

Amivantamab Plus Lazertinib Yields OS Advantage in Asia Cohort of MARIPOSA Trial in EGFR-Mutated NSCLC - OncLive

Amivantamab Plus Lazertinib Yields OS Advantage in Asia Cohort of MARIPOSA Trial in EGFR-Mutated NSCLC OncLive

IMM2510 Induces Early Efficacy in Advanced, Immunotherapy-Exposed Squamous NSCLC - OncLive

IMM2510 Induces Early Efficacy in Advanced, Immunotherapy-Exposed Squamous NSCLC OncLive

EU Approves MMR IHC Panel pharmDx as a Companion Diagnostic for Nivolumab/Ipilimumab in MSI-H/dMMR CRC - OncLive

EU Approves MMR IHC Panel pharmDx as a Companion Diagnostic for Nivolumab/Ipilimumab in MSI-H/dMMR CRC OncLive

Perioperative Tislelizumab Wins EU Approval for Resectable NSCLC at High Risk of Recurrence - OncLive

Perioperative Tislelizumab Wins EU Approval for Resectable NSCLC at High Risk of Recurrence OncLive

Shield Blood Test Yields High Sensitivity, Specificity for CRC Screening in Expansion Cohort of Average-Risk Adults - OncLive

Shield Blood Test Yields High Sensitivity, Specificity for CRC Screening in Expansion Cohort of Average-Risk Adults OncLive

Ashling Murphy: Partner settles defamation case against BBC - BBC

Ashling Murphy: Partner settles defamation case against BBC BBC

Bain invests in automation expert Ashling Partners - Consulting.us

Bain invests in automation expert Ashling Partners Consulting.us

To Deploy Generative AI Successfully, Look to Earlier Automations - Bain & Company

To Deploy Generative AI Successfully, Look to Earlier Automations Bain & Company

Ashling Murphy's partner resolves BBC defamation case over victim impact statement - Dublin Live

Ashling Murphy's partner resolves BBC defamation case over victim impact statement Dublin Live

ONO-4578 Plus Nivolumab/Chemo Improves PFS in HER2– Advanced Gastric Cancer - OncLive

ONO-4578 Plus Nivolumab/Chemo Improves PFS in HER2– Advanced Gastric Cancer OncLive

Pooled Analysis Shows Manageable Safety Profile With Tepotinib in MET Exon 14+ NSCLC - OncLive

Pooled Analysis Shows Manageable Safety Profile With Tepotinib in MET Exon 14+ NSCLC OncLive

A400/EP0031 NDA Accepted for Review in China for RET Fusion–Positive NSCLC - OncLive

A400/EP0031 NDA Accepted for Review in China for RET Fusion–Positive NSCLC OncLive

Frontline EIK1001 Plus Chemoimmunotherapy Stimulates Antitumor Activity in Advanced NSCLC - OncLive

Frontline EIK1001 Plus Chemoimmunotherapy Stimulates Antitumor Activity in Advanced NSCLC OncLive

BRF14 Data Demonstrate Long-Term Efficacy of Imatinib in Advanced GIST - OncLive

BRF14 Data Demonstrate Long-Term Efficacy of Imatinib in Advanced GIST OncLive

Timing of Real-World Belzutifan-Related AEs Varies Between VHL-Associated Tumors and Sporadic RCC - OncLive

Timing of Real-World Belzutifan-Related AEs Varies Between VHL-Associated Tumors and Sporadic RCC OncLive

SHR-4849 Shows Activity With Manageable Safety in Relapsed Small Cell Lung Cancer - OncLive

SHR-4849 Shows Activity With Manageable Safety in Relapsed Small Cell Lung Cancer OncLive

KIM-1 Represents a Potential Biomarker for Outcomes and Response in RCC - OncLive

KIM-1 Represents a Potential Biomarker for Outcomes and Response in RCC OncLive

SHR-4849 Shows Preliminary Activity With Manageable Safety in Relapsed Small Cell Lung Cancer - OncLive

SHR-4849 Shows Preliminary Activity With Manageable Safety in Relapsed Small Cell Lung Cancer OncLive

Taletrectinib Demonstrates Durable Responses in TKI-Naive and -Pretreated ROS1+ NSCLC - OncLive

Taletrectinib Demonstrates Durable Responses in TKI-Naive and -Pretreated ROS1+ NSCLC OncLive

Lutetium Lu 177 Dotatate Yields Partial Responses in Metastatic Bronchopulmonary Neuroendocrine Tumors - OncLive

Lutetium Lu 177 Dotatate Yields Partial Responses in Metastatic Bronchopulmonary Neuroendocrine Tumors OncLive

TT125-802 Earns FDA Fast Track Designations for EGFR+ and KRAS G12C+ Advanced NSCLC - OncLive

TT125-802 Earns FDA Fast Track Designations for EGFR+ and KRAS G12C+ Advanced NSCLC OncLive

Firmonertinib Demonstrates Antitumor Activity, CNS Responses in EGFR PACC–Mutated NSCLC - OncLive

Firmonertinib Demonstrates Antitumor Activity, CNS Responses in EGFR PACC–Mutated NSCLC OncLive

Ashling Murphy: Five family members of Josef Puska jailed - BBC

Ashling Murphy: Five family members of Josef Puska jailed BBC

Elironrasib Receives FDA Breakthrough Therapy Designation for Pretreated KRAS G12C+ NSCLC - OncLive

Elironrasib Receives FDA Breakthrough Therapy Designation for Pretreated KRAS G12C+ NSCLC OncLive

VT3989 Receives FDA Orphan Drug Designation for Mesothelioma - OncLive

VT3989 Receives FDA Orphan Drug Designation for Mesothelioma OncLive

Ashling Announces Support for Altera’s Agilex™ 5 FPGA Family in their RiscFree™ SDK and Toolchain - The AI Journal

Ashling Announces Support for Altera’s Agilex™ 5 FPGA Family in their RiscFree™ SDK and Toolchain The AI Journal

First-Line Osimertinib Plus Chemo Boosts OS in EGFR+ NSCLC - OncLive

First-Line Osimertinib Plus Chemo Boosts OS in EGFR+ NSCLC OncLive

American automation consultancy Ashling arrives in Australia - Consultancy.com.au

American automation consultancy Ashling arrives in Australia Consultancy.com.au

Ashling Releases a Debug and Trace Probe: Vitra-XS - Embedded Computing Design

Ashling Releases a Debug and Trace Probe: Vitra-XS Embedded Computing Design

Ashling to supply toolchain for MIPS RISC-V cores ... - eeNews Europe

Ashling to supply toolchain for MIPS RISC-V cores ... eeNews Europe

Ashling Murphy trial: Kicking legs were 'cry for help,' court hears - BBC

Ashling Murphy trial: Kicking legs were 'cry for help,' court hears BBC

Thousands gather across UK and Ireland to remember Ashling Murphy - The Guardian

Thousands gather across UK and Ireland to remember Ashling Murphy The Guardian

Q&A: Ashling Kearns, VP EMEA marketing, Salesforce: Why AI can help marketers now - Marketing Tech News

Q&A: Ashling Kearns, VP EMEA marketing, Salesforce: Why AI can help marketers now Marketing Tech News

Ashling Murphy murder accused to face trial in June - BBC

Ashling Murphy murder accused to face trial in June BBC

Arm and RISC-V Software Development Solution from Ashling: RiscFree™ for Arm & RISC-V - Business Wire

Arm and RISC-V Software Development Solution from Ashling: RiscFree™ for Arm & RISC-V Business Wire

Ashling Murphy: Thousands gather at Ireland and UK vigils - BBC

Ashling Murphy: Thousands gather at Ireland and UK vigils BBC

Ashling Murphy’s killing has shocked Ireland – but will it change a culture of misogyny? | Caelainn Hogan - The Guardian

Ashling Murphy’s killing has shocked Ireland – but will it change a culture of misogyny? | Caelainn Hogan The Guardian

Ashling Murphy killing: Irish police arrest man - BBC

Ashling Murphy killing: Irish police arrest man BBC

Ashling Murphy: thousands pay last respects to teacher killed in Ireland - The Guardian

Ashling Murphy: thousands pay last respects to teacher killed in Ireland The Guardian

Ashling Murphy: Further arrest in murder investigation - BBC

Ashling Murphy: Further arrest in murder investigation BBC

Ashling Murphy: Victim impact statements from her family and boyfriend - BBC

Ashling Murphy: Victim impact statements from her family and boyfriend BBC

Ashling Murphy: Man sentenced to life for Irish teacher's murder - BBC

Ashling Murphy: Man sentenced to life for Irish teacher's murder BBC

Ashling Murphy: 'Only something powerful can come out of this' - BBC

Ashling Murphy: 'Only something powerful can come out of this' BBC

Jozef Puska, 31, charged with murder of Ashling Murphy - BBC

Jozef Puska, 31, charged with murder of Ashling Murphy BBC

'I am the murderer': The trial of Ashling Murphy's killer - The Journal

'I am the murderer': The trial of Ashling Murphy's killer The Journal

Ashling Murphy: Second man arrested by police in probe into primary school teacher's murder - Sky News

Ashling Murphy: Second man arrested by police in probe into primary school teacher's murder Sky News

Witness said she heard person in hedge ‘cry for help’, Ashling Murphy murder trial told - BreakingNews.ie

Witness said she heard person in hedge ‘cry for help’, Ashling Murphy murder trial told BreakingNews.ie

Ashling Murphy: Pictures of vigils for murdered teacher - BBC

Ashling Murphy: Pictures of vigils for murdered teacher BBC

Gardaí expand searches as Ashling Murphy murder suspect remains in custody - The Irish Times

Gardaí expand searches as Ashling Murphy murder suspect remains in custody The Irish Times

'I am not far-right' insists boyfriend of murdered Ashling Murphy - Dublin Live

'I am not far-right' insists boyfriend of murdered Ashling Murphy Dublin Live

Cork's camogie star Ashling Thompson tells of 'losing control of life' after car crash - Cork Beo

Cork's camogie star Ashling Thompson tells of 'losing control of life' after car crash Cork Beo

Death of Ashling Murphy must be a 'watershed moment to end violence against women' - BreakingNews.ie

Death of Ashling Murphy must be a 'watershed moment to end violence against women' BreakingNews.ie

Vigils across Ireland to take place in memory of Ashling Murphy - BreakingNews.ie

Vigils across Ireland to take place in memory of Ashling Murphy BreakingNews.ie

Cork Camogie's Ashling Thompson's relationship with top GAA star, day job and tattoo meanings - RSVP Live

Cork Camogie's Ashling Thompson's relationship with top GAA star, day job and tattoo meanings RSVP Live

Top Ashling Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant